You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Graft-versus-host-disease prophylaxis

Showing 51 - 75 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic GVHD, Allogeneic Stem Cell Transplant Trial in Boston (App, Usual Care)

Recruiting
  • Chronic Graft-Versus-Host Disease
  • Allogeneic Stem Cell Transplant
  • App
  • Usual Care
  • Boston, Massachusetts
    Massachusetts General Hospital Cancer Center
Jan 24, 2023

Acute GVHD, Hematopoietic and Lymphoid System Tumor Trial in Duarte (Cholestyramine, Leflunomide, Steroid Therapy)

Recruiting
  • Acute Graft Versus Host Disease
  • Hematopoietic and Lymphoid System Neoplasm
  • Duarte, California
    City of Hope Medical Center
Jan 5, 2023

Mesenchymal Stem Cells Trial in Shapingba (Mesenchymal Stem Cells (MSCs))

Recruiting
  • Mesenchymal Stem Cells
  • Mesenchymal Stem Cells (MSCs)
  • Shapingba, Chongqing, China
    Xinqiao Hospital
Nov 24, 2023

GVHD Trial in Tampa (Cultured Treg cells)

Completed
  • Graft Versus Host Disease
  • Cultured Treg cells
  • Tampa, Florida
    H Lee Moffitt Cancer Center
Nov 2, 2022

Hematologic Malignancy, Myeloid Malignancy Trial in Memphis (Ruxolitinib, Mesna, Anti-thymocyte globulin (ATG))

Recruiting
  • Hematologic Malignancy
  • Myeloid Malignancy
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Nov 7, 2022

Acute Graft-versus-host Disease Trial in Duarte (GDC-8264)

Recruiting
  • Acute Graft-versus-host Disease
  • Duarte, California
    City of Hope National Medical Center
Jan 12, 2023

Chronic Graft Vs. Host Disease Trial (INCA34176)

Available
  • Chronic Graft Vs. Host Disease
  • (no location specified)
Sep 14, 2022

Chronic GVHD Trial in United States (Ofatumumab)

Completed
Has Results
  • Chronic Graft Versus Host Disease
  • Phoenix, Arizona
  • +3 more
Sep 30, 2022

Acute GVHD, Gastrointestinal Tract Acute GVHD, Severe Gastrointestinal Tract Acute GVHD Trial in Los Angeles (Fecal Microbiota

Not yet recruiting
  • Acute Graft Versus Host Disease
  • +3 more
  • Fecal Microbiota Transplantation Capsule
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Sep 16, 2022

GVHD (GvHD) Trial in Cardiff (Thymoglobulin, Cyclophosphamide, Cyclosporine)

Recruiting
  • Graft Versus Host Disease (GvHD)
  • Cardiff, Wales, United Kingdom
    University Hospital of Wales
May 10, 2021

Evaluation of the Impact of Reduced Immunosuppression

Enrolling by invitation
  • Graft Vs Host Disease
  • Dallas, Texas
    Methodist Dallas Medical Center
Dec 20, 2022

Steroid-refractory Acute Graft-versus-Host Disease, Treatment-refractory Acute Graft-versus-Host Disease Trial in United States

Completed
  • Steroid-refractory Acute Graft-versus-Host Disease
  • Treatment-refractory Acute Graft-versus-Host Disease
  • Neihulizumab (ALTB-168)
  • Duarte, California
  • +12 more
Jan 17, 2023

Leukemia, Lymphoma, GVHD Trial in Australia, United States (cyclosporine, cyclosporine and methotrexate)

Terminated
  • Leukemia
  • +2 more
  • Los Angeles, California
  • +12 more
May 3, 2021

Chronic Graft-versus-Host-Disease, Allogeneic Hematopoietic Stem Cell Transplantation, Leukemia Trial

Not yet recruiting
  • Chronic Graft-versus-Host-Disease
  • +4 more
    • (no location specified)
    Jan 11, 2023

    Graft Vs Host Disease, Acute-graft-versus-host Disease, Chronic Graft-versus-host-disease Trial in Boston (Exercise, Attention

    Recruiting
    • Graft Vs Host Disease
    • +2 more
    • Exercise
    • Attention control
    • Boston, Massachusetts
    • +1 more
    Nov 28, 2022

    Hematopoietic Stem Cell Transplantation, Acute GVHD, Acute Myeloid Leukemia Trial in United States (CD24Fc, Placebo,

    Terminated
    Has Results
    • Hematopoietic Stem Cell Transplantation
    • +4 more
    • Duarte, California
    • +3 more
    Oct 18, 2022

    Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Chronic Myeloid Leukemia Trial in San Francisco (CD34+ enriched, T Cell

    No longer available
    • Acute Lymphoblastic Leukemia
    • +11 more
    • CD34+ enriched, T Cell Depleted donor stem cell product
    • San Francisco, California
      University of California, San Francisco
    May 25, 2021

    Chronic GVHD, Steroid Refractory GVHD Trial in Duarte (Leflunomide)

    Recruiting
    • Chronic Graft Versus Host Disease
    • Steroid Refractory Graft Versus Host Disease
    • Duarte, California
      City of Hope Medical Center
    Sep 14, 2022

    Chronic GVHD Trial in Duarte (Belumosudil, Placebo, Prednisone)

    Recruiting
    • Chronic Graft Versus Host Disease
    • Duarte, California
      City of Hope Site Number : 8400001
    Nov 23, 2023

    GVHD Trial in Paris (Cyclophosphamide, Anti-Thymocyte Globulin, Conditioning regimen)

    Completed
    • Graft vs Host Disease
    • Paris, France
      Saint Antoine Hospital - Hematology Department
    Nov 19, 2020

    Allogeneic Hematopoietic Stem Cell Transplantation Trial in Milwaukee (MLN9708)

    Completed
    • Allogeneic Hematopoietic Stem Cell Transplantation
    • Milwaukee, Wisconsin
      Froedtert Hospital and the Medical College of Wisconsin
    Nov 1, 2020

    GVHD, Postbiotics, Butyrate Trial in Seoul (sodium butyrate)

    Recruiting
    • Graft Versus Host Disease
    • +2 more
    • sodium butyrate
    • Seoul, Korea, Republic of
      Soonchunhyang University Seoul Hospital
    Apr 11, 2023

    Acute GVHD Trial in Kansas City (MSCTC-0010 Dose Escalation)

    Recruiting
    • Acute Graft Versus Host Disease
    • MSCTC-0010 Dose Escalation
    • Kansas City, Kansas
      Kansas University Cancer Center
    Jan 30, 2023

    Acute Leukemia, MDS Trial in Atlanta (Interferon gamma (IFN?)-primed human bone marrow-derived mesenchymal stromal cells)

    Recruiting
    • Acute Leukemia
    • Myelodysplastic Syndromes
    • Interferon gamma (IFNγ)-primed human bone marrow-derived mesenchymal stromal cells
    • Atlanta, Georgia
    • +2 more
    Jul 15, 2022

    Transplant-Related Disorder Trial in Tianjin (Ruxolitinib)

    Recruiting
    • Transplant-Related Disorder
    • Tianjin, Tianjin, China
      Institute of Hematology & Blood Diseases Hospital
    Jan 28, 2023